Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Weight loss estimates are based on typical GLP-1 clinical trial results for your BMI category
National supply may be adequate while local pharmacies experience shortages Distribution bottlenecks affect product availability at individual pharmacies Patients seek compounded alternatives whenever facing access barriers Supply chain disruptions lead to varying availability across regions FDA monitors supply-demand interactions while allowing temporary compounding These interactions create a complex landscape where patients and healthcare providers must navigate between branded medications and compounded alternatives, often balancing availability with access considerations
6 ,
patients reported fewer side effects and better blood sugar control compared to Semaglutide
Mottalib A, Salsberg V, Mohd-Yusof BN et al (2018) Effects of nutrition therapy on HbA 1c and cardiovascular disease risk factors in overweight and obese patients with type 2 diabetes
(2009) 296(4):H997H1006
US$ 21.50
US$ 25.30
US$ 24.44
US$ 24.12
US$ 25.10
